期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细胞凋亡抑制蛋白研究进展 被引量：7

下载PDF
导出
摘要 自从杆状病毒中分离出凋亡抑制蛋白（IAPs）后，凋亡蛋白抑制剂的种类和数量逐渐增多。现对新发现和正在研究中的细胞凋亡抑制蛋白进行归纳和阐述，以为肿瘤治疗策略提供新的思路和理论依据。
作者 石亮（综述） 陈晓东（审校） 林向阳（审校）
机构地区 温州医学院附属第一医院检验科
出处 《国际检验医学杂志》 CAS 2007年第2期153-155,共3页 International Journal of Laboratory Medicine
关键词 肿瘤蛋白质类 抑制蛋白 细胞凋亡
分类号 R730.3 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1Concannon CG, Orrenius S, Samali A. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c[J]. Gene Expr, 2001, 9(4-5): 195-201.
  • 2Paul C, Manero F, Gonin S, et al. Hsp27 as a negative regulator of cytochrome C release[J]. Mol Cell Biol, 2002, 22(3): 816-834.
  • 3Masters SC, Yang H, Datta SR, et al. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136 [J]. Mol Pharmacol, 2001, 60(6): 1325-1331.
  • 4Nomura M, Shimizu S, Sugiyama T, et al. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax[J]. J Biol Chem, 2003, 278(3): 2058-2065.
  • 5Suzuki A, Kawano H, Hayashida M, et al. Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A[J]. Cell Death Differ, 2000, 7(8): 721-728.
  • 6Turner BC, Krajewski S, Krajewska M, et al. BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer[J]. J Clin Oncol, 2001, 19(4): 992-1000.
  • 7Shindoh M, Adachi M, Higashino F, et al. BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma [J]. Oral Oncol, 2000,36(5) : 444-449.
  • 8姜桦,曹斌融.细胞凋亡调控蛋白FAP-1、bag1与子宫内膜异位症的相关性[J].复旦学报（医学版）,2004,31(2):142-145. 被引量：2
  • 9Wang H, Yu S, Davis AT, et al. Cell cycle dependent regulation of protein kinase CK2 signaling to the nuclear matrix [J]. J Cell Biochem, 2003, 88(4): 812-822.
  • 10Bergamaschi D, Samuels Y, O'Neil NJ, et al. iASPP oncoprotein is a key inhihitor of p53 conserved from worm to human[J]. Nat Genet, 2003, 33(2): 162-167.

二级参考文献21

  • 1ELLIOTT PJ,ROSS JS. The proteasome: a new target for novel drug therapies[J]. Am J Clin Pathol, 2001,116(5) :637-646.
  • 2LIGHTCAP ES, McCORMACK TA, PIEN CS, et al. Proteasome inhibition measurements:clinical application[J]. Clin Chem, 2000,46(5) :673-683.
  • 3PAPANDREOU C,DALIANI D,MILLIKAN RE, et al. Phase I study of intravenous (I. V.) proteasome inhibitor PS-341 in patients(pts) with advanced malignancies[ J ]. Proc Am Soc Clin Oncol, 2001,20(11) :86.
  • 4HAMILTON AL,EDER J,PAVLICK AC, et al. PS-341 :phase I study of a novel proteasome inhibitor with pharmacodynamic endpoints[J]. Proc Am Soc Clin Oncol, 2001,20(11) :85.
  • 5STINCHOCOMBE TE,MITCHELL BS,DEPCIK-SMITH N, et al .PS-341 is active in multiple myeloma: preliminary report of a phase I trial of the proteasome inhibitor PS-341in patients with hematologic malignancies[ J ]. Blood, 2000,96 ( 11P1 ) : 516.
  • 6ADAMS J,PALOMBELLA VJ, SAUSVILLE EA, et al. Proteasome inhibitors:a novel class of potent and effective antitumor agents[J]. Cancer Res, 1999,59(11) :2615-2622.
  • 7CUSACK JC Jr, LIU R, HOUSTON M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341 : implications for systemic nuclear factor-κB inhibiton[J]. Cancer Res,2001,61(9):3535-3540.
  • 8HIDESHIMA T, RICHARDSON P, CHAUHAN D, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis,and overcomes drug resistance in human multiple myeloma cells[J]. Cancer Res, 2001,61(7) :3071-3076.
  • 9SHAH SA, POTTER MW, McDADE TP, et al. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer[ J ]. J Cell Biochem, 2001,82( 1 ) : 110-112.
  • 10AN WG,HWANG SG,TREPEL JB, et al. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent marks pf proteasome inhibition[ J ]. Leukemia 2000,14 (7) : 1276-1283.

共引文献2

同被引文献86

引证文献7

二级引证文献14

国际检验医学杂志
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部